Huberman Lab highlights microdosing trend and researcher perspective
2 Sep 21 4:21 PM · 2d ago · 1 post · 1 source · development 2 of 2
Andrew Huberman's lab account posted about the microdosing trend, noting it reduces side effects and costs, and shared commentary from Dr. Chris Thompson, a Harvard Medical School professor of medicine.
“"Microdosing" — a term taken from the psychedelic community, has become a popular way for people to take GLP meds with fewer side effects, and continually.”
@hubermanlabDr. Chris Thompson Professor of Medicine, Harvard Medical School
The whole story articlesposts the bright band is this development · numbered dots are the others · click one to jump
What people said 1 voice · verbatim
-
“Microdosing” — a term taken from the psychedelic community, has become a popular way for people to take GLP meds with fewer side effects, and continually. Not to mention reduced cost. Dr Chris Thompson MD, Professor of Medicine at Harvard Medical School explains.
All 2 developments of Microdosing GLP-1 drugs gains attention as lower-cost… →
Google NewsX